Company / Cost of Revenue
Ensign Group Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$4.0B
FY2025
5-year range
$2.0B / $4.0B
FY2021-FY2025
Trend
+19.0%
vs FY2024
Sector context
#21 of 113
Health Care
What the data says
Ensign Group's cost of revenue of $4.0B is higher than 81% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 8 consecutive years, from $1.3B in FY2017 to $4.0B in FY2025.
Based on SEC 10-K filings.
$4.0B in FY2025 with a 5-year CAGR of +16.6%. Top quartile in the Health Care sector.
Increased from $2.9B to $4.0B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +19.5%
- 5-Year CAGR
- +16.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 113This company $4.0B Sector average $11.3B
▼
-64.4% below sector average
Key checks
Key Insights
- Ensign Group's cost of revenue has grown for 8 consecutive years.
- 5-year CAGR of +16.6%, indicating consistent growth.
- In FY2025, cost of revenue increased 19.0% year-over-year.
- Ranks #21 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0B | +19.0% |
| FY2024 | $3.4B | +14.8% |
| FY2023 | $2.9B | +24.9% |
| FY2022 | $2.4B | +16.6% |
| FY2021 | $2.0B | +8.3% |
| FY2020 | $1.9B | +15.1% |
| FY2019 | $1.6B | +14.3% |
| FY2018 | $1.4B | +8.0% |
| FY2017 | $1.3B | -2.1% |
| FY2016 | $1.3B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026